230 related articles for article (PubMed ID: 16712666)
1. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
[TBL] [Abstract][Full Text] [Related]
2. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
[TBL] [Abstract][Full Text] [Related]
3. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
[TBL] [Abstract][Full Text] [Related]
4. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
Knochenhauer ES; Cortet-Rudelli C; Cunnigham RD; Conway-Myers BA; Dewailly D; Azziz R
J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
[TBL] [Abstract][Full Text] [Related]
5. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
[TBL] [Abstract][Full Text] [Related]
6. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
[TBL] [Abstract][Full Text] [Related]
7. Genetic defects in the cyp21a2 gene in heterozygous girls with premature adrenarche and adolescent females with hyperandrogenemia.
Neocleous V; Shammas C; Phedonos AP; Karaoli E; Kyriakou A; Toumba M; Phylactou LA; Skordis N
Georgian Med News; 2012 Sep; (210):40-7. PubMed ID: 23045419
[TBL] [Abstract][Full Text] [Related]
8. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW
Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
[TBL] [Abstract][Full Text] [Related]
9. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
Ostlere LS; Rumsby G; Holownia P; Jacobs HS; Rustin MH; Honour JW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
[TBL] [Abstract][Full Text] [Related]
10. Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status.
Dolzan V; Prezelj J; Vidan-Jeras B; Breskvar K
Eur J Endocrinol; 1999 Aug; 141(2):132-9. PubMed ID: 10427156
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.
Vakili R; Baradaran-Heravi A; Barid-Fatehi B; Gholamin M; Ghaemi N; Abbaszadegan MR
Horm Res; 2005; 63(3):119-24. PubMed ID: 15775714
[TBL] [Abstract][Full Text] [Related]
12. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
[TBL] [Abstract][Full Text] [Related]
14. Refractory acne and 21-hydroxylase deficiency in a selected group of female patients.
Caputo V; Fiorella S; Curiale S; Caputo A; Niceta M
Dermatology; 2010; 220(2):121-7. PubMed ID: 20110635
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis.
Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Małunowicz EM; Wójcicka A; Miśkiewicz P; Macech M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):23-9. PubMed ID: 26331608
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency.
Weintrob N; Brautbar C; Pertzelan A; Josefsberg Z; Dickerman Z; Kauschansky A; Lilos P; Peled D; Phillip M; Israel S
Eur J Endocrinol; 2000 Sep; 143(3):397-403. PubMed ID: 11022183
[TBL] [Abstract][Full Text] [Related]
17. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.
Witchel SF; Lee PA; Suda-Hartman M; Hoffman EP
Biochem Mol Med; 1997 Dec; 62(2):151-8. PubMed ID: 9441866
[TBL] [Abstract][Full Text] [Related]
18. Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH).
Koren I; Weintrob N; Kebesch R; Majdoub H; Stein N; Naor S; Segev-Becker A
J Clin Endocrinol Metab; 2024 Feb; 109(3):852-857. PubMed ID: 37715965
[TBL] [Abstract][Full Text] [Related]
19. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests.
Witchel SF; Lee PA
Am J Med Genet; 1998 Apr; 76(4):337-42. PubMed ID: 9545098
[TBL] [Abstract][Full Text] [Related]
20. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women.
Blanché H; Vexiau P; Clauin S; Le Gall I; Fiet J; Mornet E; Dausset J; Bellanné-Chantelot C
Hum Genet; 1997 Nov; 101(1):56-60. PubMed ID: 9385370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]